{ "cik": 1339970, "cik_padded": "0001339970", "entityName": "aTYR PHARMA INC", "fiscal_years": [ { "accn": "0001339970-26-000008", "filed": "2026-03-05", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 77000.0, "cash": 10743000.0, "eps_diluted": -0.8, "free_cash_flow": -62063000.0, "net_income": -74118000.0, "operating_cash_flow": -61986000.0, "operating_income": -77627000.0, "revenue": 190000.0, "stockholders_equity": 67480000.0, "total_assets": 93003000.0 }, "period_end": "2025-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": -0.19148936170212766, "roa_avg2y": -0.780875822433402, "roa_period_end": -0.7969420341279314, "roe_avg2y": -1.078087840638841, "roe_period_end": -1.0983698873740368 } }, { "accn": "0001339970-26-000008", "filed": "2026-03-05", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 65000.0, "cash": 11055000.0, "eps_diluted": -0.86, "free_cash_flow": -69184000.0, "net_income": -64023000.0, "operating_cash_flow": -69119000.0, "operating_income": -67914000.0, "revenue": 235000.0, "stockholders_equity": 70019000.0, "total_assets": 96830000.0 }, "period_end": "2024-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": -0.3342776203966006, "roa_avg2y": -0.5887632596570767, "roa_period_end": -0.6611897139316327, "roe_avg2y": -0.796915551074516, "roe_period_end": -0.914366100629829 } }, { "accn": "0001339970-26-000008", "filed": "2026-03-05", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 4215000.0, "cash": 22544000.0, "eps_diluted": -0.94, "free_cash_flow": -37436000.0, "net_income": -50389000.0, "operating_cash_flow": -33221000.0, "operating_income": -54919000.0, "revenue": 353000.0, "stockholders_equity": 90658000.0, "total_assets": 120653000.0 }, "period_end": "2023-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": -0.9660119391488542, "roa_avg2y": -0.4656184883500663, "roa_period_end": -0.41763569907088927, "roe_avg2y": -0.6216182874625282, "roe_period_end": -0.555814158706347 } }, { "accn": "0000950170-25-038888", "filed": "2025-03-13", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 1641000.0, "cash": 9981000.0, "eps_diluted": -1.6, "free_cash_flow": -43527000.0, "net_income": -45338000.0, "operating_cash_flow": -41886000.0, "operating_income": -46404000.0, "revenue": 10386000.0, "stockholders_equity": 71464000.0, "total_assets": 95786000.0 }, "period_end": "2022-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": -0.42908722666250243, "roa_period_end": -0.47332595577641823, "roe_avg2y": -0.5016236550217132, "roe_period_end": -0.6344173290048136 } }, { "accn": "0000950170-24-031584", "filed": "2024-03-14", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 192000.0, "cash": 2336000.0, "eps_diluted": -1.77, "free_cash_flow": -33267000.0, "net_income": -33768000.0, "operating_cash_flow": -33075000.0, "operating_income": -34015000.0, "stockholders_equity": 109301000.0, "total_assets": 115537000.0 }, "period_end": "2021-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": -0.4377977868964042, "roa_period_end": -0.2922700087417883, "roe_avg2y": -0.47914523486885513, "roe_period_end": -0.3089450233758154 } }, { "accn": "0000950170-23-007873", "filed": "2023-03-14", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 202000.0, "cash": 16952000.0, "eps_diluted": -1.77, "free_cash_flow": -15503000.0, "net_income": -16224000.0, "operating_cash_flow": -15301000.0, "operating_income": -15911000.0, "revenue": 10455000.0, "stockholders_equity": 31650000.0, "total_assets": 38726000.0 }, "period_end": "2020-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": 23.774881516587676, "roa_avg2y": -0.4331366633740022, "roa_period_end": -0.41894334555595725, "roe_avg2y": -0.6141267317737906, "roe_period_end": -0.51260663507109 } }, { "accn": "0000950170-23-007873", "filed": "2023-03-14", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 79000.0, "cash": 9210000.0, "free_cash_flow": -20092000.0, "net_income": -16224000.0, "operating_cash_flow": -20013000.0, "operating_income": -22978000.0, "revenue": 422000.0, "stockholders_equity": 21186000.0, "total_assets": 36188000.0 }, "period_end": "2019-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": -0.3648548361706434, "roa_period_end": -0.44832541173869783, "roe_avg2y": -0.5917280618571741, "roe_period_end": -0.7657887284055508 } }, { "accn": "0001564590-21-014940", "filed": "2021-03-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 594000.0, "cash": 22962000.0, "free_cash_flow": -31657000.0, "net_income": -34515000.0, "operating_cash_flow": -31063000.0, "operating_income": -32820000.0, "stockholders_equity": 33650000.0, "total_assets": 52746000.0 }, "period_end": "2018-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": -0.4857812401038698, "roa_period_end": -0.6543624161073825, "roe_avg2y": -0.7051432657439093, "roe_period_end": -1.025705794947994 } }, { "accn": "0001564590-21-014940", "filed": "2021-03-24", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 1312000.0, "cash": 21091000.0, "free_cash_flow": -43676000.0, "net_income": -48207000.0, "operating_cash_flow": -42364000.0, "operating_income": -47145000.0, "stockholders_equity": 64245000.0, "total_assets": 89355000.0 }, "period_end": "2017-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": -0.567545135066724, "roa_period_end": -0.5394997481954004, "roe_avg2y": -0.7588904806133212, "roe_period_end": -0.7503618958673826 } }, { "accn": "0001564590-20-013208", "filed": "2020-03-26", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 600000.0, "cash": 38388000.0, "free_cash_flow": -53461000.0, "net_income": -57855000.0, "operating_cash_flow": -52861000.0, "operating_income": -57940000.0, "stockholders_equity": 62801000.0, "total_assets": 80524000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_period_end": -0.7184814465252596, "roe_period_end": -0.9212432923042627 } } ], "latest_filing": { "accn": "0001339970-26-000008", "filed": "2026-03-05", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001339970.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001339970.json" }, "ticker": "ATYR" }